FRIDAY JANUARY 16TH, 2026
Canadian Breast Cancer Conference
| 11:00 AM – 12:00 PM | Registration and Light Lunch – Frontenac Foyer |
| 11:45 AM – 12:00 PM | Opening Remarks – Dr. Wendy Lam & Dr. Stephen Chia – Frontenac Ballroom AB |
| 12:00 PM – 1:05 PM | Precision Medicine Chair: Dr. Stephen Chia |
| 12:00 PM – 12:10 PM | Case Presentations – Dr. Stephen Chia |
| 12:10 PM – 12:35 PM | Current Role for Use of Genomic Assays in ER+/HER2- Early Stage Breast Cancer – Dr. Kevin Kalinsky |
| 12:35 PM – 12:50 PM | Is There a Role for ctDNA in Detecting MRD in Early Stage Breast Cancer? – Dr. Dave Cescon |
| 12:50 PM – 1:05 PM | Case Discussion and Questions & Answers Chair: Dr. Stephen Chia Panel: Dr. Dave Cescon & Dr. Kevin Kalinsky |
| 1:05 PM – 4:10 PM | Early Breast Cancer Chair: Dr. Mita Manna |
| 1:15 PM – 1:25 PM | Case Presentations – Dr. Mita Manna |
| 1:25 PM – 1:50 PM | Current Strategies and Ongoing Development of Neoadjuvant Systemic Therapy in Early Stage Breast Cancer – Dr. Dave Cescon |
| 1:50 PM – 2:10 PM | Debate – Is Completion Lymph Node Dissection Standard of Care In Post Neoadjuvant Chemotherapy Patient with 1-2 Positive Sentinel Lymph Nodes? Yes, for Axillary Dissection – Dr. Muriel Brackstone No – Dr. May Lynn Quan |
| 2:10 PM – 2:30 PM | How Low Can We Go? Updates on Breast Radiotherapy Ultra-hypofractionation, Partial Breast Radiation, and Radiation Omission for Early Breast Cancer – Dr. Iwa Kong |
| 2:30 PM – 2:45 PM | Refreshment Break – Frontenac Foyer |
| 2:45 PM – 3:05 PM | Update on the role of adjuvant CDK 4/6 inhibitors in ER+/HER-2 breast cancer – Dr. Stephen Chia |
| 3:05 PM – 3:25 PM | Managing Late Recurrences in ER+ Early Stage Breast Cancer – Dr. Kevin Kalinsky |
| 3:25 PM – 4:10 PM | Early Stage Breast Tumour Board and Panel Discussion Chair: Dr. Mita Manna Panel: Dr. Christine Brezden-Masley, Dr. Iwa Kong, Dr. May Lynn Quan, Dr. Kevin Kalinsky, Dr. Dave Cescon |
| 4:10 PM – 5:30 PM | Metastatic Breast Cancer – CNS Chair: Dr. Nathalie LeVasseur |
| 4:10 PM – 4:20 PM | Case Presentations – Dr. Nathalie LeVasseur |
| 4:20 PM – 4:40 PM | Best Practices in Management of CNS Mets – Dr. Katarzyna Jerzak |
| 4:40 PM – 5:00 PM | Update on the role and long term effects of stereotactic radiosurgery for limited brain metastases – Dr. Justin Oh |
| 5:00 PM – 5:30 PM | Case Discussion and Question & Answer Chair: Dr. Nathalie LeVasseur Panel: Dr. Katarzyna Jerzak & Dr. Justin Oh |
| 5:30 PM – 6:30 PM | Symposium Recent Updates in the 1st Line Therapy of Metastatic TNBC -Dr. Sara Hurvitz, Dr. David Cescon & Dr. Stephen Chia- Frontenac Ballroom C |
| 6:30 PM – 7:30 PM | Welcome Reception – Frontenac Ballroom C and Foyer |
| 6:40 PM – 7:30 PM | Young Investigators’ Poster Presentations Judges: Dr. Natalie LeVasseur, Dr. Katarzyna Jerzak, Dr. Anil Abraham Joy, Dr. Christine Brezden-Masley |
SATURDAY JANUARY 17TH, 2026
Canadian Breast Cancer Conference
| 7:00 AM – 7:30 AM | Express Workout with Michael Kurz – Halifax Room 3rd Floor |
| 8:00 AM – 9:00 AM | Breakfast Symposium Optimal Management strategies for ESR 1 mutated MBC. – Dr. Komal Jhaveri – Frontenac Ballroom C |
| 9:00 AM – 9:05 AM | Opening Remarks – Dr. Wendy Lam & Dr. Stephen Chia – Frontenac Ballroom AB |
| 9:05 AM – 9:10 AM | Canadian Breast Cancer Young Investigators Award – Dr. Nathalie LeVasseur |
| 9:10 AM – 10:25 AM | Metastatic Disease Chair: Dr. Anil Abraham Joy |
| 9:10 AM – 9:20 AM | Case Presentations – Dr. Anil Abraham Joy |
| 9:20 AM – 9:45 AM | Management of TNBC Beyond First Line Therapy – Dr. Komal Jhaveri |
| 9:45 AM – 10:05 AM | Therapeutic approaches post 1st line CDK 4/6 inhibitor based therapy: Targeting pathways beyond ESR1 – Dr. Sara Hurvitz |
| 10:05 AM – 10:25 AM | Is there a new standard of care in 1st line therapy of HER-2 positive MBC? – Dr. Nathalie LeVasseur |
| 10:25 AM – 10:45 AM | Refreshment Break – Frontenac Foyer |
| 10:45 AM – 12:30 PM | Metastatic Disease Chair: Dr. Anil Abraham Joy |
| 10:45 AM – 11:05 AM | Development of Regional Care Pathway for Drug Induced Interstitial Lung Disease (ILD) – Dr. Stephen Chia |
| 11:05 AM – 11:25 AM | Case Discussion: TNBC and HER-2 positive MBC and Q&A Chair: Dr. Anil Abraham Joy Panel: Dr. Nathalie LeVasseur, Dr. Komal Jhaveri, Dr. Sarah Hurvitz |
| 11:25 AM – 12:30 PM | Metastatic Breast Tumour Board Chair: Dr. Simon Yu Panel: Dr. Christine Brezden, Dr. Sara Hurvitz, Dr. Iwa Kong, Dr. Melina Deban |
| 12:40 PM – 1:40 PM | Lunch Symposium Current Insights on ADC Therapy in Metastatic Breast Cancer – An Expert Panel Discussion- Dr. Komal Jhaveri, Dr. Mita Manna, Dr. Nathalie LeVasseur |
| 1:40 PM – 3:00 PM | Survivorship Chair: Dr. Vanessa Bernstein |
| 1:40 PM – 1:50 PM | Introduction – Dr. Vanessa Bernstein |
| 1:50 PM – 2:10 PM | Survivorship: A Patient Journey and Perspective – Ms. Melissa Riding |
| 2:10 PM – 2:30 PM | Hot Flashes, Hard Facts: Menopause and Hereditary Risk After Breast Cancer – Dr. Lesa Dawson |
| 2:30 PM – 3:00 PM | Panel Discussion and Question & Answer Chair: Dr. Vanessa Bernstein Panel: Ms. Melissa Riding, Dr. Lesa Dawson |
| 3:00 PM – 3:10 PM | Closing Remarks – Dr. Wendy Lam & Dr. Stephen Chia |
SUNDAY JANUARY 18TH, 2025
| 7:00 AM – 7:30 AM | Express Workout with Michael Kurz – Halifax Room 3rd Floor |